Join SightNation!

Become a citizen of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Connect with Colleagues

Link up with professionals all over the nation. Share your ideas, thoughts and opinions. Collaborate on difficult cases and offer your insights.

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling. Post questions to your peers.

Learn and Advance

Take CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on the latest eye care industry news.

Unite!

Engage with SightNation citizens to help create real reform on issues affecting the industry. Start or join groups about the issues most important to you.

Create an account and receive access to the personalized box below.

Apply for Citizenship!
view counter

What’s Going On Across the Nation

New Blog Postings

SightNation News

Featured News

AMD Risk Score From OCT Data - 12.18.2014

Stanford University scientists have found a new way to forecast which patients with age-related macular degeneration are likely to suffer from the most debilitating form of the disease. More »

Featured News

Parameters Expanded for Biofinity Multifocal Contact Lens - 12.17.2014

CooperVision Inc. More »

Featured News

SciFluor Life Sciences Awarded U.S. Patent for Topical Treatment of Retinal Disease - 12.16.2014

SciFluor Life Sciences LLC recently announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,901,144 with claims covering the novel compound SF0166. More »

Featured News

Eidon Retinal Imaging System Cleared for Sale in the U.S. - 12.15.2014

CenterVue has received FDA clearance for its Eidon true-color confocal scanner, a fully automated retinal imaging system that combines the advantages of confocal scanning with true-color imaging capab More »

Iluvien Granted Marketing Authorization in the Netherlands - 12.12.2014

The Dutch Inspectie voor de Gezondheidszorg has granted marketing authorization to Iluvien for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficient More »

Copyright © 2010 Jobson Medical Information LLC. All Rights Reserved.